A Conformable Ultrasound Patch for Cavitation‐Enhanced Transdermal Cosmeceutical Delivery
Source abstract
Abstract
Abstract Increased consumer interest in healthy‐looking skin demands a safe and effective method to increase transdermal absorption of innovative therapeutic cosmeceuticals. However, permeation of small‐molecule drugs is limited by the innate barrier function of the stratum corneum. Here, a conformable ultrasound patch (cUSP) that enhances transdermal transport of niacinamide by inducing intermediate‐frequency sonophoresis in the fluid coupling medium between the patch and the skin is reported. The cUSP consists of piezoelectric transducers embedded in a soft elastomer to create localized cavitation pockets (0.8 cm2, 1 mm deep) over larger areas of conformal contact (20 cm2). Multiphysics simulation models, acoustic spectrum analysis, and high‐speed videography are used to characterize transducer deflection, acoustic pressure fields, and resulting cavitation bubble dynamics in the coupling medium. The final system demonstrates a 26.2‐fold enhancement in niacinamide transport in a porcine model in vitro with a 10 min ultrasound application, demonstrating the suitability of the device for short‐exposure, large‐area application of sonophoresis for patients and consumers suffering from skin conditions and premature skin aging.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Microencapsulation and Drying Processes · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Media Lab Massachusetts Institute of Technology Cambridge MA 02139 USA
Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology Cambridge MA 02139 USA
Department of Mechanical and Aerospace Engineering University at Buffalo Buffalo NY 14260 USA
Funding
National Science Foundation
References (86)
Show source-provided references
1. 10.1039/C4RA02861A10.1039/C4RA02861A ↗
2. 10.1016/j.biomaterials.2014.03.04310.1016/j.biomaterials.2014.03.043 ↗
3. 10.1016/j.jconrel.2013.12.03010.1016/j.jconrel.2013.12.030 ↗
4. 10.1208/s12248-012-9377-y10.1208/s12248-012-9377-y ↗
5. 10.1038/nbt.150410.1038/nbt.1504 ↗
6. 10.1038/nrd130410.1038/nrd1304 ↗
7. 10.1016/S0928-0987(01)00167-110.1016/S0928-0987(01)00167-1 ↗
8. 10.22270/jddt.v2i1.7410.22270/jddt.v2i1.74 ↗
9. Venkatesh D N. · Int. J. Res. Pharm. Sci. · 2012 · 3 · 71
10. 10.3390/pharmaceutics401007110.3390/pharmaceutics4010071 ↗
11. 10.1016/j.jconrel.2016.04.03010.1016/j.jconrel.2016.04.030 ↗
12. 10.3390/pharmaceutics704043810.3390/pharmaceutics7040438 ↗
13. 10.1021/acsnano.7b0489810.1021/acsnano.7b04898 ↗
14. 10.1016/S0006-3495(03)74770-510.1016/S0006-3495(03)74770-5 ↗
15. 10.1080/03639045.2018.153949710.1080/03639045.2018.1539497 ↗
16. 10.1016/j.biomaterials.2007.12.04810.1016/j.biomaterials.2007.12.048 ↗
17. 10.1039/C8LC00098K10.1039/C8LC00098K ↗
18. 10.1016/j.addr.2003.10.02310.1016/j.addr.2003.10.023 ↗
19. 10.1016/j.addr.2003.10.02610.1016/j.addr.2003.10.026 ↗
20. 10.1016/j.addr.2003.10.02710.1016/j.addr.2003.10.027 ↗
21. 10.1038/sj.jid.570024810.1038/sj.jid.5700248 ↗
22. 10.1211/jpp.61.06.000110.1211/jpp.61.06.0001 ↗
23. 10.1517/17425247.2010.53867910.1517/17425247.2010.538679 ↗
24. 10.1016/S0006-3495(03)74770-510.1016/S0006-3495(03)74770-5 ↗
25. 10.1208/s12249-019-1309-z10.1208/s12249-019-1309-z ↗
26. 10.1111/ics.1235010.1111/ics.12350 ↗
27. OxSonics Therapeutics https://oxsonics.com/(accessed: July 2022).
28. SonoTarg https://sonotarg.com/cancer‐therapy‐technology/(accessed: July 2022).
29. Kikushi K. · 2018 · 101
30. 10.1111/srt.1312910.1111/srt.13129 ↗
31. 10.1007/978-3-319-68237-210.1007/978-3-319-68237-2 ↗
32. 10.1016/j.jconrel.2011.01.00610.1016/j.jconrel.2011.01.006 ↗
33. 10.1111/j.0909-752X.2006.00186.x10.1111/j.0909-752X.2006.00186.x ↗
34. 10.1007/978-1-4899-1262-610.1007/978-1-4899-1262-6 ↗
35. 10.1126/science.763860310.1126/science.7638603 ↗
36. 10.1023/A:101609662681010.1023/A:1016096626810 ↗
37. 10.1121/1.512686510.1121/1.5126865 ↗
38. 10.1016/S0378-5173(01)00820-110.1016/S0378-5173(01)00820-1 ↗
39. 10.1023/A:101097901090710.1023/A:1010979010907 ↗
40. 10.1016/j.ultrasmedbio.2018.01.02110.1016/j.ultrasmedbio.2018.01.021 ↗
41. 10.1016/j.ijpharm.2020.11913710.1016/j.ijpharm.2020.119137 ↗
42. 10.1016/j.ultsonch.2012.04.01310.1016/j.ultsonch.2012.04.013 ↗
43. 10.1016/S0168-3659(00)00344-810.1016/S0168-3659(00)00344-8 ↗
44. 10.1016/j.ijpharm.2017.02.00210.1016/j.ijpharm.2017.02.002 ↗
45. 10.1007/s00296-012-2634-710.1007/s00296-012-2634-7 ↗
46. 10.1021/bp00002410.1021/bp000024 ↗
47. 10.1016/S0168-3659(02)00054-810.1016/S0168-3659(02)00054-8 ↗
48. 10.1021/acsnano.1c1118110.1021/acsnano.1c11181 ↗
49. 10.1088/1361-665X/ac08ae10.1088/1361-665X/ac08ae ↗
50. 10.1108/FS-07-2020-006710.1108/FS-07-2020-0067 ↗
51. 10.1016/j.eml.2016.05.01510.1016/j.eml.2016.05.015 ↗
52. 10.1121/10.001428610.1121/10.0014286 ↗
53. 10.1016/S0378-5173(01)00981-410.1016/S0378-5173(01)00981-4 ↗
54. 10.1121/1.190742810.1121/1.1907428 ↗
55. 10.1016/j.ultsonch.2017.04.03710.1016/j.ultsonch.2017.04.037 ↗
56. 10.1121/1.214315110.1121/1.2143151 ↗
57. 10.1016/j.crhy.2006.10.01510.1016/j.crhy.2006.10.015 ↗
58. 10.1088/0960-1317/21/4/04500210.1088/0960-1317/21/4/045002 ↗
59. K.Johnston Ph.D. thesis University of Dundee Dundee UK2016 p. 198.
60. 10.1021/jp014656610.1021/jp0146566 ↗
61. 10.1109/TUFFC.2018.286779310.1109/TUFFC.2018.2867793 ↗
62. 10.1016/j.ultsonch.2010.11.01610.1016/j.ultsonch.2010.11.016 ↗
63. 10.1016/S0378-5173(01)00981-410.1016/S0378-5173(01)00981-4 ↗
64. 10.1121/1.190746410.1121/1.1907464 ↗
65. 10.1201/9780429202971-4310.1201/9780429202971-43 ↗
66. 10.1002/(SICI)1097-0185(199704)247:4<455::AID-AR3>3.0.CO;2-Q10.1002/(SICI)1097-0185(199704)247:4<455::AID-AR3>3.0.CO;2-Q ↗
67. 10.3390/pharmaceutics1209088710.3390/pharmaceutics12090887 ↗
68. 10.3390/pharmaceutics1305072610.3390/pharmaceutics13050726 ↗
69. 10.1007/s40005-012-0040-510.1007/s40005-012-0040-5 ↗
70. 10.1016/S0168-3659(02)00464-910.1016/S0168-3659(02)00464-9 ↗
71. 10.1016/S0168-3659(99)00178-910.1016/S0168-3659(99)00178-9 ↗
72. 10.1016/j.jconrel.2014.08.00710.1016/j.jconrel.2014.08.007 ↗
73. 10.1016/j.ijpharm.2018.11.06510.1016/j.ijpharm.2018.11.065 ↗
74. 10.4155/tde.14.3210.4155/tde.14.32 ↗
75. 10.1002/1520-6017(200105)90:5<545::AID-JPS1012>3.0.CO;2-H10.1002/1520-6017(200105)90:5<545::AID-JPS1012>3.0.CO;2-H ↗
76. 10.1097/00000542-199306000-0001110.1097/00000542-199306000-00011 ↗
77. 10.1007/s10439-019-02383-110.1007/s10439-019-02383-1 ↗
78. 10.1038/s41598-020-61924-010.1038/s41598-020-61924-0 ↗
79. 10.4103/2229-5178.18546810.4103/2229-5178.185468 ↗
80. 10.1073/pnas.070018210410.1073/pnas.0700182104 ↗
81. 10.1038/nmat428910.1038/nmat4289 ↗
82. 10.1063/1.492767710.1063/1.4927677 ↗
83. 10.1016/j.jconrel.2015.02.00210.1016/j.jconrel.2015.02.002 ↗
84. 10.2147/IJN.S17475910.2147/IJN.S174759 ↗
85. 10.1088/0960-1317/18/6/06700110.1088/0960-1317/18/6/067001 ↗
86. T.Andersen M. A. E.Andersen O. C.Thomsen inProc. 2012 COMSOL Conf. COMSOL Göttingen Germany https://www.comsol.com/paper/download/151765/andersen_paper.pdf.